STC:DBD's 5-Year Yield-on-Cost % is ranked better than 65.96% of 517
companies
in the Drug Manufacturers industry
Industry Median: 2.27
vs STC:DBD: 3.93
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Binh Dinh Pharmaceutical And Medical Equipment JSC 5-Year Yield-on-Cost % Related Terms
STC:DBD vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binh Dinh Pharmaceutical And Medical Equipment JSC 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
Binh Dinh Pharmaceutical And Medical Equipment JSC 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a 5-Year Yield-on-Cost % of 3.93 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. This is 20% above median its historical median of 3.27. Over the past decade, Binh Dinh Pharmaceutical And Medical Equipment JSC's 5-Year Yield-on-Cost % has ranged from 2.27 to 5.22. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #176 out of 517 companies in the Drug Manufacturers industry, placing it in the top 34%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's 5-Year Yield-on-Cost % too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current 5-Year Yield-on-Cost % of 3.93 is 20% above median its 10-year median of 3.27. Over the past 10 years, this metric has ranged from a low of 2.27 to a high of 5.22. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.27. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 3.93 is 73.1% above this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #176 out of 517 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #176 out of 517 companies for 5-Year Yield-on-Cost %. This puts Binh Dinh Pharmaceutical And Medical Equipment JSC in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.27. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 3.93 is 73.1% above this benchmark. Historically, Binh Dinh Pharmaceutical And Medical Equipment JSC's own 5-Year Yield-on-Cost % has ranged from 2.27 to 5.22 over the past decade. While the company's 10-year median is 3.27 vs. the industry median of 2.27, Binh Dinh Pharmaceutical And Medical Equipment JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.27, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current 5-Year Yield-on-Cost % of 3.93 is 73.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current 5-Year Yield-on-Cost % is 3.93, which is 20% above median its own 10-year median of 3.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,363.37, compared to a current price of ₫51,200.00 — trading 2.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.93, which is 20% above median its 10-year median of 3.27 and 73.1% above the Drug Manufacturers industry median of 2.27. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current 5-Year Yield-on-Cost % is 3.93 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be undervalued.
The current stock price of ₫51,200.00 is trading 2.2% below its estimated GF Value™ of ₫52,363.37.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
5-Year Yield-on-Cost %: 3.93 (20% above median its 10-year median of 3.27)
GF Value™: ₫52,363.37 vs. price of ₫51,200.00 (2.2% below fair value)
Industry Position: 73.1% above the Drug Manufacturers median (#176 of 517)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 